Daniel Sumarriva, Executive Medical Director at SAGA Diagnostics, shared a post on LinkedIn:
“Grateful for the opportunity to speak at the ‘Annual Best of Breast Conference’ this past weekend, an exceptional meeting that brings together the breast cancer community and excels at turning podium data into decisions that matter for patients.
We discussed the growing need for longitudinal ctDNA Surveillance in Breast Cancer, particularly as survivorship expands and expectations around sensitivity and clinical actionability evolve. The engagement in the room made it clear how critical this topic is across practice settings.
Thank you to Total Health | Oncology for hosting this important event.”
More posts featuring Daniel Sumarriva.
